A study to screen for lung cancer in high-risk individuals who have never smoked using low-dose computed tomography (LDCT). - NEMO

Study identifier:D133FR00247

ClinicalTrials.gov identifier:NCT07914881

EudraCT identifier:N/A

CTIS identifier:N/A

Will Be Recruiting

Official Title

LungScreen-NEMO: Prospective national lung cancer screening study in high-risk never-smokers

Medical condition

lung cancer, Thoracic Tumors

Phase

-

Healthy volunteers

no

Study drug

-

Sex

All

Estimated Enrollment

200

Study type

Observational

Age

40 Years - 74 Years

Date

Study Start Date: 30 Nov 2026
Estimated Primary Completion Date: 30 Oct 2030
Estimated Study Completion Date: 30 Oct 2030

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Oct 2026 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria